Sickle cell disease (SCD) comprises a group of genetic blood disorders that affect the hemoglobin
molecular structure, and in some cases, the association with hemoglobin synthesis. In sickle cell anemia, the replacement of glutamic acid by valine at the 6th position on the beta chain from the N terminal results in the synthesis of the abnormal hemoglobin, called hemoglobin S(HbS).
